{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:06:48Z","timestamp":1758416808446,"version":"3.44.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jns.2020.116994","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T11:30:28Z","timestamp":1592479828000},"page":"116994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Huntingtons disease: A new evidence of neurovascular dysfunction"],"prefix":"10.1016","volume":"416","author":[{"given":"Claudio","family":"Campa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116994_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.121","article-title":"An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity","volume":"3","author":"Cisbani","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jns.2020.116994_bb0010","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/S0042-6989(96)00169-1","article-title":"Ocular motor abnormalities in Huntington\u2019s disease","volume":"37","author":"Lasker","year":"1997","journal-title":"Vis. Res."},{"key":"10.1016\/j.jns.2020.116994_bb0015","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s00415-015-7869-2","article-title":"Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression","volume":"262","author":"Kersten","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2020.116994_bb0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.26486","article-title":"Spectral-domain optical coherence tomography as a potential biomarker in Huntington\u2019s disease","volume":"31","author":"Andrade","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2020.116994_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/JHD-170255","article-title":"Enhanced retinal responses in Huntington\u2019s disease patients","volume":"6","author":"Pearl","year":"2017","journal-title":"J Huntington\u2019s Dis"},{"key":"10.1016\/j.jns.2020.116994_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","article-title":"Neurovascular abnormalities in humans and mice with Huntington\u2019s disease","volume":"250","author":"Lin","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2020.116994_bb0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20303312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20303312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:51:51Z","timestamp":1758383511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20303312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":7,"alternative-id":["S0022510X20303312"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116994","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huntingtons disease: A new evidence of neurovascular dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116994"}}